Shi, B., Behrens, C., Vaghani, V., Riquelme, E. M., Rodriguez‐Canales, J., Kadara, H., . . . Simon, G. (2019). Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non‐small cell lung cancer. Cancer Med.
Citação norma ChicagoShi, Bin, et al. "Oncogenic Enhancer of Zeste Homolog 2 Is an Actionable Target in Patients With Non‐small Cell Lung Cancer." Cancer Med 2019.
MLA引文Shi, Bin, et al. "Oncogenic Enhancer of Zeste Homolog 2 Is an Actionable Target in Patients With Non‐small Cell Lung Cancer." Cancer Med 2019.
警告：這些引文格式不一定是100％准確.